TickerFactsScreenerDevelopers

VERTEX PHARMACEUTICALS INC / MA (VRTX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2008: -$462.71M2009: -$614.01M2010: -$696.08M2011: $113.82M2012: $46.73M2013: -$610.01M2014: -$692.41M2015: -$466.88M2016: $9.94M2017: $123.24M2018: $635.15M2019: $1.20B2020: $2.86B2021: $2.78B2022: $4.31B2023: $3.83B2024: -$232.90M2025: $4.17B$4.17B
2008Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$4.17B+1891.9%
2024-$232.90M-106.1%
2023$3.83B-11.0%
2022$4.31B+54.8%
2021$2.78B-2.6%
2020$2.86B+138.5%
2019$1.20B+88.5%
2018$635.15M+415.4%
2017$123.24M+1140.4%
2016$9.94M+102.1%
2015-$466.88M+32.6%
2014-$692.41M-13.5%
2013-$610.01M-1405.5%
2012$46.73M-58.9%
2011$113.82M+116.4%
2010-$696.08M-13.4%
2009-$614.01M-32.7%
2008-$462.71M—